Faculty of Nursing
Amman, Aljubeiha, 11942, Jordan
NCT Number: NCT07423832
Here is a plain-language, registry-appropriate Brief Summary you can paste into the form. It is written for patients, families, and healthcare providers:
Brief Summary
This study examines whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can reduce the severity of symptoms in adults experiencing post-traumatic stress disorder (PTSD) in Jordan. PTSD can develop after exposure to distressing or traumatic life events and may cause symptoms such as intrusive memories, avoidance, sleep problems, anxiety, and emotional distress.
A total of 70 adult participants with moderate to severe PTSD symptoms were enrolled. Participants were assigned to one of two groups: an EMDR therapy group or a waitlist control group. Individuals in the EMDR group received structured therapy sessions delivered by a trained mental-health professional, while those in the waitlist group did not receive therapy during the study period but were offered treatment after the study ended.
PTSD symptom severity was measured before treatment, immediately after the therapy sessions, and again one month later. The goal of the study was to determine whether EMDR therapy leads to meaningful and lasting reductions in PTSD symptoms compared with no immediate treatment.
The findings of this research are intended to help healthcare providers and policymakers understand the value of EMDR as a non-pharmacological, evidence-based treatment option for individuals experiencing trauma-related distress, and to support improvements in mental-health services and trauma-informed care in Jordan.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Amman, Aljubeiha, 11942, Jordan
Post-traumatic stress disorder (PTSD) is a mental-health condition that may develop after exposure to traumatic or highly distressing events and is associated with significant functional, emotional, and physical consequences. Evidence-based psychological therapies are essential to reduce symptom burden and improve quality of life, particularly in settings where access to specialized trauma services may be limited.
This study evaluates the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy, a structured, trauma-focused psychotherapeutic approach, in reducing the severity of PTSD symptoms among adults in Jordan. The investigation uses a quasi-experimental design with an intervention group receiving EMDR sessions and a waitlist control group receiving no immediate therapeutic intervention during the study period. Symptom severity is assessed at baseline, immediately after completion of the intervention, and at a one-month follow-up to examine both immediate and short-term outcomes.
EMDR therapy is delivered by a licensed mental-health professional trained in the standardized EMDR protocol. The intervention focuses on processing traumatic memories through guided recall combined with bilateral stimulation techniques (such as eye movements), with the aim of decreasing emotional distress and strengthening adaptive cognitive responses. Participants in the waitlist control group are offered the same therapeutic sessions after completion of outcome assessments to ensure equitable access to care.
The study seeks to generate empirical evidence regarding the clinical utility, feasibility, and short-term sustainability of EMDR therapy in a Middle Eastern context. Findings are intended to inform mental-health practitioners, nursing professionals, and healthcare decision-makers about the potential role of EMDR as a non-pharmacological, trauma-informed treatment option for adults experiencing moderate to severe PTSD symptoms.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adults aged 18 years or older
Probable PTSD or moderate-to-severe post-traumatic stress symptoms based on the screening instrument used in the study
Exposure to at least one traumatic or highly stressful life event within the previous six months
No prior receipt of EMDR therapy
Willingness and ability to provide informed consent and participate in therapy sessions and assessments
Exclusion criteria
Acute cognitive or intellectual disability that would interfere with comprehension of study procedures or questionnaires
Significant visual impairment or visual pathology that would prevent full engagement with the visual components of EMDR therapy
Inability to communicate effectively by phone for scheduled assessments
Refusal or inability to provide informed consent
Participants received Eye Movement Desensitization and Reprocessing (EMDR) therapy, a structured trauma-focused psychotherapy delivered individually by a licensed psychiatric mental-health professional trained in the standardized EMDR protocol. Sessions lasted approximately 90 minutes and were conducted three times per week over the intervention period. The protocol followed the established EMDR phases, including history taking, preparation, identification of target memories, bilateral stimulation (e.g., guided eye movements or alternating taps), installation of adaptive cognitions, body scan, closure, and reevaluation. Outcomes were measured at baseline, immediately post-intervention, and at one-month follow-up.
Time frame: Baseline, immediately after intervention, and 1-month follow-up.
Severity of post-traumatic stress symptoms measured using the Primary Care Post-Traumatic Stress Disorder Screen (PC-PTSD) questionnaire at baseline (T0), immediately post-intervention (T1), and one-month follow-up (T2).
Al-Quds University
Other
Psychiatric Nurse-Delivered Eye Movement Desensitization and Reprocessing (EMDR) for Adults With Post-Traumatic Stress Symptoms in Jordan: A Randomized Controlled Trial
Acronym: Experimental
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07550556
Behavior, Combat Disorders
Rome, RM, Italy
View Trial DetailsNCT06957210
Combat Disorders, Mental Disorders
Nowshera, KPK, Pakistan
View Trial DetailsNCT06955845
Behavior, Combat Disorders
Nowshera, KPK, Pakistan
View Trial DetailsNCT07080606
Behavior, Combat Disorders
Lexington, Kentucky, United States
View Trial Details